Tilmicosin formulation

Details Tilmicosin formulation Tilmicosin formulation

1995-01-13

1996-11-12

Peselev, Elli

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

536 71, A61K 3170

Patent

active

055740200

ABSTRACT:
An aqueous, injectable, sustained release tilmicosin formulation comprises 250-350 mg/ml of tilmicosin and 250 mg/ml of propylene glycol, and has a pH adjusted to 6.

REFERENCES:
patent: 4820695 (1989-04-01), Debono et al.
E. E. Ose et al., "Single-dose Treatment of Neonatal Calf Pneumonia with the new Macrolide Antibiotic Tilmicosin", Veterinary Record (1988) 123, 367-369.

Affiliated with

Also associated with

Rating

Tilmicosin formulation does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Tilmicosin formulation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tilmicosin formulation will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-562601